These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16707032)

  • 1. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML; Wiker C; Svensson TH
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
    Marcus MM; Wiker C; Frånberg O; Konradsson-Geuken A; Langlois X; Jardemark K; Svensson TH
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):891-903. PubMed ID: 19835668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
    Hertel P; Fagerquist MV; Svensson TH
    Science; 1999 Oct; 286(5437):105-7. PubMed ID: 10506554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat.
    Marcus MM; Jardemark KE; Wadenberg ML; Langlois X; Hertel P; Svensson TH
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):315-27. PubMed ID: 15857571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
    Masana M; Bortolozzi A; Artigas F
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat.
    Linnér L; Wiker C; Wadenberg ML; Schalling M; Svensson TH
    Neuropsychopharmacology; 2002 Nov; 27(5):691-8. PubMed ID: 12431844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
    Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in rats.
    Jacobson SM; Prus AJ
    Behav Pharmacol; 2010 Oct; 21(7):654-9. PubMed ID: 20729715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level.
    Hertel P; Nomikos GG; Svensson TH
    Eur J Pharmacol; 1999 Apr; 371(2-3):153-8. PubMed ID: 10357252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha2-adrenoceptor antagonism is neither sufficient nor necessary for the distinctive action of atypical neuroleptics on intracranial self-stimulation in the rat.
    Montgomery AM; Grottick AJ; Herberg LJ
    Behav Pharmacol; 2003 Jul; 14(4):307-14. PubMed ID: 12838036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
    Wadenberg MG; Browning JL; Young KA; Hicks PB
    Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.
    Marcus MM; Jardemark K; Malmerfelt A; Björkholm C; Svensson TH
    Neuropsychopharmacology; 2010 Aug; 35(9):1952-61. PubMed ID: 20463659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
    Invernizzi RW; Garavaglia C; Samanin R
    Neuropsychopharmacology; 2003 May; 28(5):872-9. PubMed ID: 12644843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.
    Wadenberg ML; Hertel P; Fernholm R; Hygge Blakeman K; Ahlenius S; Svensson TH
    J Neural Transm (Vienna); 2000; 107(10):1229-38. PubMed ID: 11129112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.
    Eltayb A; Wadenberg ML; Schilström B; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):195-202. PubMed ID: 16284783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
    Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
    Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.